Acarix

With over 15 years of R&D and 45 patents, the #CADScor System is a cutting-edge tool for risk stratifying patients at the point of care. It will elevate your practice and build trust with your patients. See the impact firsthand and schedule a demo today. Our expert sales team is ready to show you how our innovative system can transform your approach to patient care. https://lnkd.in/gW_9J7tD

At Acarix, we're making cardiac #healthcare more accessible with our innovative CADScor System. Our CE-approved and FDA DeNovo-cleared device: - Uses acoustic analysis to assess coronary blood flow - Rapidly rules out significant coronary artery disease at point of care - Potential to reduce unnecessary, invasive procedures Learn how we're transforming the future of #CardiacCare: https://lnkd.in/gmXC6gix

Curious about our CADScor System? Explore our FAQs for more information: https://lnkd.in/gE9UeNBB

As a Cardiac Nurse, Sydney spends her days identifying heart disease symptoms in her patients but she never imagined facing them herself. That changed when she felt a tingling sensation down her arm. Discover how our #CADScor System became an essential part of Sydney’s journey to better #HeartHealth: https://lnkd.in/gkKyWp7G

It is important for both patients and #healthcare systems to be able to reduce unnecessary patient examinations and significant costs when patients come in with chest pain. At Acarix, we're addressing this challenge head-on with our CADScor System, our #MedicalDevice designed to promptly determine if chest pain is related to significant CAD, reducing unnecessary examinations and their associated costs. Learn more about why this #MedTech is needed now more than ever: https://lnkd.in/gsTw9_K5

Imagine streamlining your cardiac assessment process for patients with suspected stable CAD. The #CADScor System is designed to support this goal. With experience from over 40,000 patient assessments, we're supporting early cardiac #healthcare decisions. Interested in how this could fit into your practice? Find out: https://lnkd.in/gsTw9_K5

Did you know up to 40% of people experience chest pain in their lifetime? Chest pain is a leading cause for doctor visits, yet 90% of these cases aren't related to significant coronary artery disease (CAD). This is why the CADScor System is a game-changer in early cardiac assessment. Our innovative technology allows physicians to rule-out CAD in patients with chest pain, streamlining diagnostics and reducing unnecessary medical testing. Transform the way we approach cardiac care with the #CADScor https://lnkd.in/gsS9wVdM

Cardiac care is entering a new #HealthInnovation era. The #CADScor System is revolutionizing how we approach coronary artery disease (CAD). With its #AI powered acoustic analysis, this technology enables healthcare providers to quickly and easily rule-out significant CAD. Don't miss out on the opportunity to transform cardiac #healthcare in your practice. Book your demo today: https://lnkd.in/gW_9J7tD

Have you heard this exciting news for Acarix and the cardiac diagnostics industry? On November 4, 2024, Centers for Medicare & Medicaid Services recently approved standalone fixed reimbursement for the #CADScor System in outpatient settings. This pivotal decision allows healthcare providers to submit standard billing claims, boosting accessibility in key areas. Read more about the approval: https://lnkd.in/gxW8aXNZ

The CADScor System: the future of cardiac diagnostics! Are you ready to discover how cutting-edge technology can transform patient care? This innovative system analyzes coronary blood flow with phenomenal reliability, setting a new standard. Learn more about how the #CADScor System can benefit your practice or facility: https://lnkd.in/gsTw9_K5